Clinical response and hospital costs associated with the empirical use of vancomycin and linezolid for hospital-acquired pneumonia in a Chinese tertiary care hospital: a retrospective cohort study

AIMS: To evaluate clinical outcomes and allocation of hospital costs associated with empirical use of vancomycin or linezolid for hospital-acquired pneumonia (HAP) in the People’s Republic of China. METHODS: Hospital episodes including HAP treated by vancomycin or linezolid between 2008 and 2012 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yuanlin, Yang, Yicheng, Chen, Wendong, Liu, Wei, Wang, Kai, Li, Xuehai, Wang, Ke, Papadimitropoulos, Manny, Montgomery, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207441/
https://www.ncbi.nlm.nih.gov/pubmed/25378939
http://dx.doi.org/10.2147/CEOR.S65900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207441/
https://www.ncbi.nlm.nih.gov/pubmed/25378939
http://dx.doi.org/10.2147/CEOR.S65900

Ejemplares similares